Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 15:18 UTC
  • 19
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 15:09 UTC
  • 19
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

Genmab (GMAB)

  • Event
  • Aug. 01, 2022, 14:42 UTC
  • 19
  • 1 comments

(99% Neutral) Genmab (GMAB) Files Form 6-K

Comment Full text

Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX)

  • Event
  • Aug. 01, 2022, 13:17 UTC
  • 22
  • 1 comments

(85% Positive) CORTEXYME, INC. (CRTX) Announces Clinical Development Update

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Aug. 01, 2022, 13:01 UTC
  • 105
  • 0 comments

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Comment Full text

EAGLE PHARMS INC (EGRX)

  • Event
  • Aug. 01, 2022, 12:31 UTC
  • 22
  • 1 comments

(99% Neutral) Eagle Pharmaceuticals, Inc. (EGRX) Announces Regulatory Update

Comment Full text

OncoCyte Corporation (OCX)

  • Event
  • Aug. 01, 2022, 12:05 UTC
  • 24
  • 1 comments

(94% Neutral) Oncocyte Corporation (OCX) Announces Clinical Development Update

Comment Full text

Chimerix Inc (CMRX)

  • Event
  • Aug. 01, 2022, 11:54 UTC
  • 23
  • 1 comments

(70% Positive) Chimerix, Inc. (CMRX) Announces Business Combination

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • Aug. 01, 2022, 11:33 UTC
  • 20
  • 1 comments

(10% Negative) HUTCHMED DRC (HCM) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

ATAI Life Sciences (ATAI)

  • Event
  • Aug. 01, 2022, 11:31 UTC
  • 23
  • 1 comments

(99% Neutral) ATAI LIFE SCIENCES N.V. (ATAI) Announces Business Combination

Comment Full text
  • Previous
  • 542
  • 543
  • 544
  • 545
  • 546
  • Next

Search

News categories

  • Technical Exchange News(12475)
  • Event(6229)
  • SEC News(283381)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161812)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin